US Patent Issued to SENSORION on Aug. 11 for "Calcineurin inhibitors of the setron family for the treatment of hearing loss" (French Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,671, issued on Aug. 11, was assigned to SENSORION (Montpellier, France).

"Calcineurin inhibitors of the setron family for the treatment of hearing loss" was invented by Jonas Dyhrfjeld-Johnsen (Lunel-Viel, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an inhibitor of calcineurin of the setron family for use for treating hearing loss in a subject in need thereof."

The patent was filed on Aug. 16, 2022, under Application No. 17/820,010.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l...